These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 27776184)
1. Deoxyarbutin Possesses a Potent Skin-Lightening Capacity with No Discernible Cytotoxicity against Melanosomes. Miao F; Shi Y; Fan ZF; Jiang S; Xu SZ; Lei TC PLoS One; 2016; 11(10):e0165338. PubMed ID: 27776184 [TBL] [Abstract][Full Text] [Related]
2. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents. Hu ZM; Zhou Q; Lei TC; Ding SF; Xu SZ J Dermatol Sci; 2009 Sep; 55(3):179-84. PubMed ID: 19574027 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809 [TBL] [Abstract][Full Text] [Related]
4. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Boissy RE; Visscher M; DeLong MA Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582 [TBL] [Abstract][Full Text] [Related]
5. Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin. Chang NF; Chen YS; Lin YJ; Tai TH; Chen AN; Huang CH; Lin CC Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467382 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the effects of hydroquinone and arbutin on the differentiation of melanocytes. Inoue Y; Hasegawa S; Yamada T; Date Y; Mizutani H; Nakata S; Matsunaga K; Akamatsu H Biol Pharm Bull; 2013; 36(11):1722-30. PubMed ID: 24189417 [TBL] [Abstract][Full Text] [Related]
7. Determination of the thermodegradation of deoxyArbutin in aqueous solution by high performance liquid chromatography. Yang CH; Chen YS; Lai JS; Hong WW; Lin CC Int J Mol Sci; 2010 Oct; 11(10):3977-87. PubMed ID: 21152314 [TBL] [Abstract][Full Text] [Related]
8. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541 [TBL] [Abstract][Full Text] [Related]
9. Experimental study on cross-reactivity of alpha-arbutin toward p-phenylenediamine and hydroquinone in guinea pigs. To-o K; Nomura K; Sugimoto K; Nishimura T; Kuriki T; Itoh M J Dermatol; 2010 May; 37(5):455-62. PubMed ID: 20536651 [TBL] [Abstract][Full Text] [Related]
10. Whitening effect of Sophora flavescens extract. Shin DH; Cha YJ; Joe GJ; Yang KE; Jang IS; Kim BH; Kim JM Pharm Biol; 2013 Nov; 51(11):1467-76. PubMed ID: 24106757 [TBL] [Abstract][Full Text] [Related]
11. An effective hydroquinone alternative for topical skin lightening. Draelos ZD; Deliencourt-Godefroy G; Lopes L J Cosmet Dermatol; 2020 Dec; 19(12):3258-3261. PubMed ID: 33098161 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues. Xiao L; Matsubayashi K; Miwa N Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222 [TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity. Bang SH; Han SJ; Kim DH J Cosmet Dermatol; 2008 Sep; 7(3):189-93. PubMed ID: 18789053 [TBL] [Abstract][Full Text] [Related]
14. Regulatory effect of hydroquinone-tetraethylene glycol conjugates on zebrafish pigmentation. Le HT; Hong BN; Lee YR; Cheon JH; Kang TH; Kim TW Bioorg Med Chem Lett; 2016 Jan; 26(2):699-705. PubMed ID: 26684849 [TBL] [Abstract][Full Text] [Related]
15. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis. Chawla S; Kvalnes K; deLong MA; Wickett R; Manga P; Boissy RE J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995 [TBL] [Abstract][Full Text] [Related]
16. Risk assessment of skin lightening cosmetics containing hydroquinone. Matsumoto M; Todo H; Akiyama T; Hirata-Koizumi M; Sugibayashi K; Ikarashi Y; Ono A; Hirose A; Yokoyama K Regul Toxicol Pharmacol; 2016 Nov; 81():128-135. PubMed ID: 27521610 [TBL] [Abstract][Full Text] [Related]
17. Using a Cellular System to Directly Assess the Effects of Cosmetic Microemulsion Encapsulated DeoxyArbutin. Chang NF; Tsai FJ; Zheng YM; Huang WH; Lin CC Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884914 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives. Chawla S; deLong MA; Visscher MO; Wickett RR; Manga P; Boissy RE Br J Dermatol; 2008 Dec; 159(6):1267-74. PubMed ID: 18811684 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of melanosome transfer results in skin lightening. Seiberg M; Paine C; Sharlow E; Andrade-Gordon P; Costanzo M; Eisinger M; Shapiro SS J Invest Dermatol; 2000 Aug; 115(2):162-7. PubMed ID: 10951231 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study. Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]